Penicillin resistance has increased sharply within the past few years among Streptococcus pneumoniae clinical isolates in many areas of the United States (11-13, 18, 23). Because of the concern for potential treatment failures due to penicillin resistance, extended-spectrum cephalosporins have been recommended by some for the empiric therapy of pneumococcal meningitis (9, 17, 24, 25 
Penicillin resistance has increased sharply within the past few years among Streptococcus pneumoniae clinical isolates in many areas of the United States (11-13, 18, 23) . Because of the concern for potential treatment failures due to penicillin resistance, extended-spectrum cephalosporins have been recommended by some for the empiric therapy of pneumococcal meningitis (9, 17, 24, 25) . However, therapeutic failures for meningitis caused by extended-spectrum cephalosporin-resistant strains were reported recently (2, 5, 16) . Therefore, clinical microbiology laboratories must be able to recognize antimicrobial resistance in pneumococci quickly and accurately. This problem has been complicated by the fact that well-standardized, practical methods for susceptibility testing of pneumococci have not been widely available. This study has evaluated the use of the E test (AB Biodisk NA, Piscataway, N.J.) for the detection of penicillin and cefotaxime resistance among 147 pneumococcal clinical isolates in three geographically separate laboratories.
MATERIALS AND METHODS
Test organisms. Approximately 50 unique isolates of S. pneumoniae were tested in each of the three laboratories (i.e., the Centers for Disease Control and Prevention, the Massachusetts General Hospital, and the University of Texas Health Science Center). They were fresh clinical isolates, isolates sent to the laboratories for confirmation of antimicrobial resistance, or isolates selected from among the laboratories' stock culture collections to ensure adequate numbers of resistant isolates. Included among the study isolates were 42 penicillin-and 14 cefotaxime-resistant isolates (see definitions of resistance below). S. pneumoniae ATCC 49619 (15) and CDC strain CS 101 (multiply-antibiotic resistant) were used as quality control strains in each laboratory. To assess interlaboratory reproducibility, each laboratory tested a coded collection of 10 strains with different levels of penicillin and cephalosporin susceptibilities.
Reference 
RESULTS
Each of three laboratories tested two S. pneumoniae control strains, 10 coded challenge strains, and approximately 50 unique clinical isolates by using the E test and the NCCLS reference broth microdilution procedure with penicillin and cefotaxime. The expected results were obtained with the control strains in all three laboratories. Table 1 depicts the interlaboratory reproducibility of results obtained with the collection of 10 strains tested in a blinded fashion by each laboratory. These strains spanned a wide range of susceptibility and resistance to both penicillin and cefotaxime. Excellent reproducibility of each test method was demonstrated in this phase of the study; i.e., 100% of penicillin MICs determined by either the E test or broth microdilution agreed within two log2 dilutions, and 96.7% of cefotaxime MICs determined by either method agreed within two log2 dilutions. Thus, the two test methods demonstrated equal interlaboratory reproducibilities with both antibiotics. (7, 10, 20) , pneumococcal strains resistant to penicillin or to four or more drugs have now been reported from several areas of the United States (11, 13, 18, 22) . Perhaps even more troubling are strains which have been found in several locales, that are resistant to various extended-spectrum cephalosporins, and have resulted in treatment failures for meningitis (2, 5, 16, 19) . Extended-spectrum cephalosporins have been recommended for the empiric therapy of serious infections due to suspected penicillin-resistant or relatively resistant pneumococci (9, 17, 24, 25) . Thus, it is important that clinical microbiology laboratories use routine susceptibility testing procedures which can quickly and accurately recognize resistant pneumococcal isolates.
The oxacillin disk test has been found to be reliable for predicting susceptibility to penicillin (11, 21) . However, the test cannot distinguish strains that are penicillin resistant (MIC, 22 ,ug/ml) from those that demonstrate relative resistance to penicillin (MICs, 0.1 to 1 ,ug/ml). Indeed, some penicillin-susceptible strains of pneumococci produce zones of <20 mm in the oxacillin disk screening test (11, 21, 26) . Thus, it may be important to define the level of penicillin susceptibility of significant pneumococcal isolates by determining an MIC. Moreover, disk diffusion testing of pneumococci for susceptibility to cephalosporins has not yet been well standardized (4, 22) . The MIC procedure recommended by the NCCLS for testing pneumococci involves the use of 2 to 5% LHB or Haemophilus test medium in a broth microdilution test format (15) . Lysed horse blood-supplemented medium is tedious to prepare and has not been widely available from commercial sources. Haemophilus test medium may be simpler to prepare or obtain commercially; however, MICs tend to be somewhat lower than those determined in LHB, a fact which can affect the interpretation of results (6), and growth failures may occur with some strains (unpublished observation).
The E test is a relatively simple method for determining the MICs of a variety of antimicrobial agents for both common and fastidious or anaerobic bacteria (1, 3, 8) . Excellent interlaboratory agreement of MICs was demonstrated in this study with both the E test and the broth microdilution procedure when a coded challenge set of pneumococcal strains was tested independently in the three laboratories. A previous study with pneumococci noted generally favorable, although imperfect, agreement of MICs determined by the E test and NCCLS broth dilution methods (8) . However, in that study, the E test involved incubation in ambient air, rather than in a CO2 environment, as in the present study. The results of this study have shown very good agreement between MICs determined by the E test (when incubated in C02) and those determined by the NCCLS broth microdilution test for penicillin and cefotaxime; i.e., 92.5 to 96.6% of MICs were within one log2 dilution. Incubation in CO2 for the pneumococcal E test improves the agreement with MICs determined by the NC-CLS LHB broth microdilution method and avoids the problem caused by the fact that some pneumococcal strains are capneic and do not grow readily under ambient air incubation conditions.
No very major or major interpretive category errors were encountered in this study with either penicillin or cefotaxime E test MICs. The majority of the minor errors observed with penicillin occurred with strains for which MICs clustered at the breakpoint separating susceptible and relatively resistant strains, i.e., 0.06 to 0.12 ,ug/ml. Only 5.4% minor errors occurred among cefotaxime E test results, on the basis of the MIC interpretive criteria selected for use in this study (i.e., susceptible, <0.25 ,ug/ml; resistant, .2 ,g/ml). These breakpoints were chosen for use in this study on the basis of reported treatment failures for meningitis caused by strains for which MICs were 2 ,ug/ml or greater (2, 5, 19) . These breakpoints are admittedly conservative and may warrant reevaluation following further clinical experience with strains for which cephalosporin MICs are in the range of 0.5 to 2 ,ug/ml. Indeed, these same MIC interpretive criteria are under consideration presently by the NCCLS (personal communication).
The results of this three-laboratory study indicate that the E test represents a reliable method for the detection of penicillin or cephalosporin resistance in pneumococci. Clinical isolates of pneumococci can be tested by the E test in a manner quite similar to that for the disk diffusion method. However, unlike oxacillin disk screening test results, penicillin E test results unambiguously define the level of penicillin susceptibility of pneumococcal isolates. In addition, use of the E test would allow prompt definition of the degree of susceptibility to an extended-spectrum cephalosporin, such as cefotaxime.
We recommend that all pneumococcal isolates from patients with meningitis be tested against penicillin and an extended-spectrum cephalosporin as soon as isolated colonies are available because of the serious consequences of inadequate antibiotic treatment (19) . Our data suggest that the E test is a convenient and accurate means of performing such testing when microdilution testing with LHB is not readily available. For pneumococcal isolates from patients without meningitis, it may be more cost-effective to screen isolates by the oxacillin disk test and pursue further testing of penicillin and alternative agents only for isolates showing zone sizes of less than 20 mm. ACKNOWLEDGMENT E test strips were kindly provided for the purposes of this study by AB Biodisk NA, Piscataway, N.J.
